CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-03). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2062 · Search date 2026-08-03 · Methodology v0.6

Curry habit,
does it really help with Lower cognitive decline and incidence of mild cognitive impairment or dementia?

30-Second Summary
C
Evidence Grade C · 45 · Safety caution
Curry frequency was linked to incident cognitive disorder, but the adjusted cognitive-decline trend was null and actual dose was unknown
Risks of curry as food depend on its ingredients, sodium, allergies, and medicines. Safety findings from high-dose turmeric or curcumin supplements cannot simply be assigned to a curry meal.
What the
research shows
The grade is C with 45 points. In a 4.5-year cohort, some curry-frequency groups had less cognitive decline, and incident mild cognitive impairment or dementia decreased across frequency. Yet the fully adjusted trend for a two-point MMSE decline was null at P=0.15, and the study measured neither curry amount, turmeric, nor curcumin, so prevention by curry or curcumin is not established.
What the
ads claim
Curry is a meal containing multiple spices and ingredients, not isolated turmeric. Verdict 064 is C with 48 points for curcumin or turmeric extract and joint outcomes; this verdict addresses whole curry meals and cognitive events.
*

Useful facts when choosing a product

  • Curry combines turmeric with other spices, fat, and main ingredients.
  • A single curry-frequency question was used, and validation of that item itself was not reported. Serving grams, turmeric grams, and curcumin milligrams were not measured, so tablespoon or pinch conversion is impossible.
  • The paper analyzed cognitive decline and incident MCI-dementia separately, and their fully adjusted patterns differed.
Gap Measurement · Verdict 2062 · C 45
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Of 5,035 participants with baseline curry data, 2,920 had follow-up MMSE data at a mean 4.5 years and 432 declined by at least two points. Incident MCI-dementia was analyzed separately in 2,446 cognitively normal participants. Exposure was a single curry-frequency question ranging from rare or never to daily, and validation of that item itself was not reported. Validation of a separate 163-item food-frequency questionnaire cannot substitute for validation of this question. Models adjusted for education but not income; serving weight, turmeric, and curcumin were not collected. No prospective analysis registration was presented, and public agencies funded the cohort.

02

Why this is classified as C (45)

A publicly funded prospective cohort found an important cognitive-event signal, but split core outcomes, unquantified exposure, and follow-up selection limit it to C with 45 points.

Counterpoint. C does not mean curry fails to prevent decline; it means the meal and dose capable of reproducing the association are unknown.

Rejudgment record. Cross-check applied — The 2025 article's two outcome tables, fully adjusted trends, selected analysis populations, exposure question, funding, and the existing curcumin verdict were cross-checked

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeEXThe clinical size of the effect could not be judged

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Lower incidence of an MMSE decline of at least two pointsDOnly one frequency group was significant and the fully adjusted overall trend was P=0.15.
Lower incident mild cognitive impairment or dementiaCThe frequency trend was positive but came from one observational cohort.
Curcumin alone explains the association?Turmeric and curcumin amounts were not measured.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Population-based prospective cohort analysis2,446Public funding from the A*STAR Biomedical Research Council and National Medical Research CouncilMMSE decline of at least two points and incident MCI-dementiaIncident MCI-dementia ORs 0.61 (0.40-0.94), 0.56 (0.35-0.89), 0.54 (0.30-0.96), and 0.21 (0.09-0.49), trend P=0.021; MMSE-decline ORs 0.73 (0.53-1.01), 0.68 (0.48-0.95), 0.74 (0.50-1.11), and 0.66 (0.41-1.06), trend P=0.150Single observational cohort with divergent core outcomes
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-03).

Lu Y, Lee TS, Lim WS, et al. Curcumin-Rich Curry Consumption Is Associated with Lower Risk of Cognitive Decline and Incidence of Mild Cognitive Impairment or Dementia: An Asian Population-Based Study. Nutrients. 2025;17(15):2488. PMID: 40806073. DOI: 10.3390/nu17152488.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none

Cite this verdict

Curry habit x less cognitive decline Evidence Grade C card
[Chamgap] Curry habit x less cognitive decline — Evidence Grade C·45. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/cognition/curry-habit-cognitive-decline/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.